Biological treatment approach to inflammatory bowel disease is similar in academic and nonacademic centres - prime time for decentralisation of inflammatory bowel disease care?
Eur J Gastroenterol Hepatol
; 36(6): 728-734, 2024 Jun 01.
Article
em En
| MEDLINE
| ID: mdl-38625825
ABSTRACT
BACKGROUND:
With the increasing number of inflammatory bowel disease (IBD) patients, it is difficult to manage them within specialised IBD teams in academic medical centres many are therefore treated in nonacademic IBD centres. It is unclear whether the time to introducing biologics is the same in both settings.AIM:
We aimed to compare treatment approach with biologics in academic vs. nonacademic centres.METHODS:
We analysed Slovenian national IBD registry data (UR-CARE Registry, supported by the European Crohn's and Colitis Organisation), which included 2 academic (2319 patients) and 4 nonacademic IBD (429 patients) centres.RESULTS:
The disease phenotype was similar in both settings. In total, 1687 patients received 2782 treatment episodes with biologics. We observed no differences in treatment episodes with TNF-alpha inhibitors (60% vs. 61%), vedolizumab (24% vs. 23%), or ustekinumab (17% vs. 16%) in academic compared to nonacademic centres ( P â =â 0.949). However, TNF inhibitors were less often the first biologic in academic centres (TNF inhibitors 67.5% vs. 74.0%, vedolizumab 20.3% vs. 17.9%, ustekinumab 12.1% vs. 8.1%; P = 0.0096). Consequently, more patients received ustekinumab (29.8% vs. 18.3%) and vedolizumab (17.4% vs. 13.5%) and fewer TNF inhibitors (52.7% vs. 68.2%) for Crohn's disease in academic compared to nonacademic centres, with no such differences for ulcerative colitis. The time to initiation of the first biologic from diagnosis was short and similar in both settings (11.3 vs. 10.4 months, P â =â 0.2).CONCLUSION:
In this nationwide registry analysis, we observed that biological treatment choice was similar in academic and nonacademic settings. These findings support the decentralisation of IBD care.
Texto completo:
1
Coleções:
01-internacional
Temas:
Cuidados_paliativos
/
Geral
Base de dados:
MEDLINE
Assunto principal:
Sistema de Registros
/
Centros Médicos Acadêmicos
/
Anticorpos Monoclonais Humanizados
Limite:
Adult
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
Europa
Idioma:
En
Revista:
Eur J Gastroenterol Hepatol
/
Eur. j. gastroenterol. hepatol
/
European journal of gastroenterology and hepatology
Assunto da revista:
GASTROENTEROLOGIA
Ano de publicação:
2024
Tipo de documento:
Article